Related references
Note: Only part of the references are listed.Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition
Amal Kamal Abdel-Aziz et al.
HAEMATOLOGICA (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
NK cells for cancer immunotherapy
Noriko Shimasaki et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Nanomedicine for improvement of dendritic cell-based cancer immunotherapy
Vida Hashemi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia
Heleen H. Van Acker et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside
Amal Kamal Abdel-Aziz et al.
EUROPEAN JOURNAL OF CANCER (2019)
Engineering dendritic cell vaccines to improve cancer immunotherapy
Caleb R. Perez et al.
NATURE COMMUNICATIONS (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches
Nehad M. Ayoub et al.
BREAST CANCER-TARGETS AND THERAPY (2019)
Dendritic cell vaccine induces antigen-specific CD8+ T cells that are metabolically distinct from those of peptide vaccine and is well-combined with PD-1 checkpoint blockade
Koji Nagaoka et al.
ONCOIMMUNOLOGY (2018)
Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy
Mandy van Gulijk et al.
FRONTIERS IN IMMUNOLOGY (2018)
The concept of immune surveillance against tumors. The first theories
Domenico Ribatti
ONCOTARGET (2017)
CD8+ T Cells Orchestrate pDC-XCR1+ Dendritic Cell Spatial and Functional Cooperativity to Optimize Priming
Anna Brewitz et al.
IMMUNITY (2017)
Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences
Nikko Brix et al.
IMMUNOLOGICAL REVIEWS (2017)
PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity
Maria Gato-Canas et al.
CELL REPORTS (2017)
The large tumor suppressor family: friend or foe?
Wei Kang et al.
JOURNAL OF THORACIC DISEASE (2017)
Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma
Robin Cornelissen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Coinhibitory Pathways in Immunotherapy for Cancer
Susanne H. Baumeister et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona et al.
BMC MEDICINE (2016)
Blood-brain barrier, cytotoxic chemotherapies and glioblastoma
Antonin Drean et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
Sofie Wilgenhof et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Blood-brain barrier, cytotoxic chemotherapies and glioblastoma
Antonin Drean et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination
Steve Boudewijns et al.
ONCOIMMUNOLOGY (2016)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
Cancer immunotherapy: harnessing the immune system to battle cancer
Yiping Yang
JOURNAL OF CLINICAL INVESTIGATION (2015)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
New genetic variants of LATS1 detected in urinary bladder and colon cancer
Mona K. Saadeldin et al.
FRONTIERS IN GENETICS (2015)
Therapeutic use of anti-CTLA-4 antibodies
Christian U. Blank et al.
INTERNATIONAL IMMUNOLOGY (2015)
Adoptive T Cell Immunotherapy for Cancer
Karlo Perica et al.
RAMBAM MAIMONIDES MEDICAL JOURNAL (2015)
Clinical use of dendritic cells for cancer therapy
Sebastien Anguille et al.
LANCET ONCOLOGY (2014)
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
Surasak Phuphanich et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer
Daniela Fenoglio et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Blockade of PD-1/PD-L1 immune checkpoint during DC vaccination induces potent protective immunity against breast cancer in hu-SCID mice
Yan Ge et al.
CANCER LETTERS (2013)
Next-generation peptide vaccines for advanced cancer
Akira Yamada et al.
CANCER SCIENCE (2013)
Generation of more effective cancer vaccines
Daniela Fenoglio et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Plasmacytoid Dendritic Cells Support Melanoma Progression by Promoting Th2 and Regulatory Immunity through OX40L and ICOSL
Caroline Aspord et al.
CANCER IMMUNOLOGY RESEARCH (2013)
ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4+ T cells by plasmacytoid dendritic cells
Julien Faget et al.
ONCOIMMUNOLOGY (2013)
Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3+ T-Regulatory Cells
Curdin Conrad et al.
CANCER RESEARCH (2012)
PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine
Jacalyn Rosenblatt et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Innate immunity and adjuvants
Shizuo Akira
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2011)
Prostate-specific antigen: an overlooked candidate for the targeted treatment and selective imaging of prostate cancer
Aaron M. LeBeau et al.
BIOLOGICAL CHEMISTRY (2010)
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Jedd D. Wolchok et al.
CLINICAL CANCER RESEARCH (2009)
Immune surveillance: a balance between protumor and antitumor immunity
Suzanne Ostrand-Rosenberg
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy
Seagal Teitz-Tennenbaum et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Imiquimod:: mode of action
M. P. Schoen et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine
Ji-Yan Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
CD8+CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers
Gilberto Filaci et al.
JOURNAL OF IMMUNOLOGY (2007)
DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus
A Marzi et al.
JOURNAL OF VIROLOGY (2004)
L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus
JP Gardner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells
B Tassaneetrithep et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection
F Halary et al.
IMMUNITY (2002)
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
TBH Geijtenbeek et al.
CELL (2000)
Share Paper
